Oncology

Cervical cancer remains one of the most daunting diagnoses a woman can face: each year, over half a million new cases are detected worldwide, and many are only identified once symptoms appear. Advances in screening and vaccination have improved early detection, yet challenges persist – from navigating complex staging to...

Ovarian cancer is a significant global health concern, ranking as the eighth most common cancer among women. In 2022, there were approximately 324,603 new cases worldwide, with over 206,000 related deaths. The disease often presents with non-specific symptoms, leading to late-stage diagnoses and a global five-year survival rate ranging...

Liver cancer is a significant global health challenge, ranking among the top causes of cancer-related deaths worldwide. In 2020 alone, approximately 905,700 new cases were diagnosed, and about 830,200 deaths were attributed to the disease. In Germany, liver cancer, while less prevalent compared to some other countries, still poses...

Gastrointestinal neuroendocrine tumors (GI NETs) are rare malignancies that originate from neuroendocrine cells located throughout the gastrointestinal tract.1 These tumors are unique because they can produce hormones and have a wide spectrum of behaviors, ranging from indolent to highly aggressive forms. Over the past few decades...

Lung cancer is one of the most prevalent and aggressive malignancies globally, significantly impacting public health. According to the German Centre for Cancer Registry Data, there were approximately 56,700 new cases of lung cancer diagnosed in Germany in 2020, with 34,100 cases in men and 22,590 in women. The age-standardized incidence...

Bile duct cancer, also known as cholangiocarcinoma, is a malignant tumor that can originate in any part of the bile duct system. Bile duct cancer is considered to be rare as compared to other types of cancer, with less than 8,000 people diagnosed with it every year. Females are less likely to suffer from the disease than males.

Facing colon cancer feels overwhelming, but you have more treatment options than ever before. While treatment for colon cancer stage 1 provides 90% five-year survival rates, even advanced cases now benefit from breakthrough therapies that deliver chemotherapy directly to tumor sites, harness your immune system's power, and use precision...

Rectal cancer is a type of carcinoma that begins in the tissues of the rectum, the final part of the large intestine. While often grouped with colon cancer, rectal cancer presents unique challenges due to its location near critical structures, such as the sphincter, bladder, and reproductive organs. In some cases, tumors extend from the rectum...